Merck Says Venezuela Currency Devaluation To Affect 2013 Operations
This article was originally published in PharmAsia News
Executive Summary
Merck said Venezuela's devaluation of its bolivar as part of a large budget-cutting effort would have a negative impact on its operations through the end of this year.